Success Story: Dual Triumph: NAILG Obtains EB1A and NIW Approvals for Chinese Scientist Innovating in Cancer Detection Technologies
Client’s Testimonial:
On October 30th, 2025, we received another I-140 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Physical Science Research Scientist in the Field of Analytical Chemistry (Approval Notice).
General Field: Analytical Chemistry
Position at the Time of Case Filing: Physical Science Research Scientist
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: October 30th, 2025 (NIW&EB1A)
Processing Time: 1 year, 1 month, 4 days (NIW), and 5 months, 14 days (EB1A, Premium Processing Requested)
Case Summary:
North America Immigration Law Group (NAILG) is honored to share the success of a distinguished analytical chemist whose groundbreaking work in rapid metabolic profiling for in vitro cancer diagnosis has earned both EB1A (Alien of Extraordinary Ability) and EB2 NIW (National Interest Waiver) approvals. His research, which integrates advanced mass spectrometry imaging and metabolic analysis, has transformed the understanding of cancer biomarkers and propelled innovation in diagnostic and therapeutic applications.
Our client holds a Ph.D. in Pharmaceutical Analysis and currently serves as a physical science research scientist. He continues to develop and refine mass spectrometry-based approaches for cancer detection and drug discovery. His pioneering investigations into spatial metabolomics, microdroplet chemistry, and biomarker identification have established him as an authority in analytical chemistry and a key contributor to global efforts in precision medicine.
Across his prolific career, our client has authored 47 peer-reviewed journal articles, including 23 first-authored papers, in top-tier scientific journals. His research has been cited 1,782 times by independent scholars from more than 50 countries, placing him among the top 1% of most-cited researchers in analytical chemistry. His groundbreaking work on mass spectrometry imaging and microdroplet interface chemistry has been instrumental in enabling faster, more accurate cancer diagnostics and sustainable chemical processes for environmental and pharmaceutical applications.
Recognized for his scientific rigor and expertise, our client has conducted at least 28 peer reviews for leading international journals and has served as a guest editor for a special issue on mass spectrometry imaging. His research has also been supported by the National Natural Science Foundation of China (NSFC), underscoring its impact and international significance.
As noted by one of his expert recommenders,
“Our client’s research is integral to the field of analytical chemistry and his contributions are crucial in continuing to drive research forward.”
The client’s innovative approaches have not only improved the accuracy of cancer detection but have also broadened the scope of analytical chemistry across biomedicine, energy, and environmental systems. With NAILG’s guidance and meticulous case strategy, both petitions were approved on October 30, 2025. The EB1A approval was granted in 5 months, 14 days under premium processing, and the NIW approval was secured the same day, marking an exceptional dual success.
NAILG is proud to have represented our client in achieving this milestone. His story stands as a testament to how visionary research, paired with precise legal advocacy, can pave the way for extraordinary scientists to continue their transformative work in the United States.

